For following the competition: what moved in each program, several studies read as one move.
- pelabresib
- elritercept
- ruxolitinib
- + 11 more
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Primary Myelofibrosis to watchlistEvery Monday by email · turn it off any timePro · free during the beta